Showing results (11-20 of 228) with videos related to
Sort By:
Pageof 23
Urology|November 24, 1999
Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomyS R Potter, M C Miller, L A Mangold, et al.Seminars in Urologic Oncology|September 19, 1998
The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancerJ Pannek, A W PartinReviews in Urology|September 21, 2006
Current Clinical Applications of the In-capromab Pendetide Scan (ProstaScint(R) Scan, Cyt-356)M Han, A W PartinOncology (Williston Park, N.Y.)|October 27, 1997
Prostate-specific antigen: what's new in 1997J Pannek, A W PartinCancer|January 3, 2001
Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomyS R Potter, L A Mangold, M J Shue, et al.Current Opinion in Urology|August 5, 2000
Diagnosis of localized prostate cancer: 10 years of progressM R Feneley, A W PartinUrology|April 11, 2001
Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agentsA W Partin, L S MarksCurrent Urology Reports|June 27, 2002
What does prostate-specific antigen recurrence mean?C R Pound, A W PartinThe Urologic Clinics of North America|October 10, 2001
Indicators of pathologic stage of prostate cancer and their use in clinical practiceM R Feneley, A W PartinRecent Progress in Hormone Research|January 1, 1994
Benign and malignant prostatic neoplasms: human studiesA W Partin, D S CoffeyPageof 23